Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Employment Services

Market Closed - Nasdaq 04:30:01 2024-03-18 pm EDT 5-day change 1st Jan Change
17.9 USD +4.50% Intraday chart for Cross Country Healthcare, Inc. -3.97% -20.94%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating MT
Transcript : Cross Country Healthcare, Inc., Q4 2023 Earnings Call, Feb 21, 2024
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q4 EPS $0.29, vs. Street Est of $0.27 MT
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q4 Revenue $414M, vs. Street Est of $404.5M MT
(CCRN) CROSS COUNTRY HEALTHCARE Expects Q1 EPS Range $0.15 - $0.25 MT
Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024 CI
Tranche Update on Cross Country Healthcare, Inc.'s Equity Buyback Plan announced on August 16, 2022. CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cross Country Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024 CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating MT
Cross Country Healthcare Insider Sold Shares Worth $119,460, According to a Recent SEC Filing MT
North American Morning Briefing : Stocks Look to -2- DJ
Jefferies Downgrades Cross Country Healthcare to Hold From Buy, Adjusts Price Target to $21 From $32 MT
Transcript : Cross Country Healthcare, Inc., Q3 2023 Earnings Call, Nov 01, 2023
Tranche Update on Cross Country Healthcare, Inc.'s Equity Buyback Plan announced on August 16, 2022. CI
Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023 CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Cross Country Healthcare, Inc. Amends its ABL Credit Agreement CI
Barrington Cuts Price Target on Cross Country Healthcare to $29 From $35 Amid Reduction in Estimates, Keeps at Outperform MT
Credit Suisse Adjusts Cross Country Healthcare's Price Target to $26 From $27, Keeps Neutral Rating MT
Chart Cross Country Healthcare, Inc.
More charts
Cross Country Healthcare, Inc. is a technology-enabled workforce solution and advisory company. The Company operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, temporary placement of healthcare leaders within nursing, allied, physician, human resources, and managed services programs (MSP) services, in-home care services, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, and government facilities.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
17.9 USD
Average target price
19.5 USD
Spread / Average Target
+8.94%
Consensus
  1. Stock
  2. Equities
  3. Stock Cross Country Healthcare, Inc. - Nasdaq
  4. News Cross Country Healthcare, Inc.
  5. Barrington Research Raises Price Target for Cross Country Healthcare to $41 From $40, Maintains Outperform Rating